Velnacrine for Alzheimer's disease
Author:
Affiliation:
1. University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD
2. University of Oxford; Nuffield Department of Medicine; John Radcliffe Hospital, Headington 4th Floor Oxford UK OX3 9DU
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004748/fullpdf
Reference26 articles.
1. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease A double-blind, placebo-controlled study Mentane Study Group;Antuono;Archives of Internal Medicine,1995
2. Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease;Clipp;Clinical Pharmacology and Therapeutics,1995
3. Alzheimer's disease and caregiver time [letter];Moore;Lancet,1994
4. Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings;Cutler;Journal of Clinical Pharmacology,1990
5. Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial;Zemlan;Journal of Neural Transmission,1996
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats;Journal of Pharmaceutical and Biomedical Analysis;2012-03
2. Velnacrine for Alzheimer's disease;Cochrane Database of Systematic Reviews;2004-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3